-+ 0.00%
-+ 0.00%
-+ 0.00%
Ping An Biomedical Regains Compliance With Nasdaq Minimum Bid Price Requirement
Share
Listen to the news
Ping An Biomedical Regains Compliance With Nasdaq Minimum Bid Price Requirement
  • Ping An Biomedical received Nasdaq confirmation of compliance with Listing Rule 5550(a)(2) on November 16, 2026, closing its bid price deficiency case.
  • Ordinary shares closed at $1 or higher for 10 consecutive business days from November 2 to November 13, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-121426), on November 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending